daewoong ipf cs pharma british

JW Pharmaceutical announced through its disclosure on Monday that it had applied last Friday for a phase 3 trial for Epaminurad, a gout treatment, w...

South Korea's leading drug company Daewoong Pharmaceutical is accelerating its global expansion efforts for its 34th domestically developed drug Fex...

Lotte Department Store on Wednesday said it will hold the first solo exhibition in Asia by Alfie Caine, a British artist who is emerging as a star o...

DAEWOONG PHARMACEUTICAL has received domestic approval for its diabetes drug Envlo with the active ingredient enavogliflozin, the second straight ye...

The UK's top watchdog for market competition on Monday accepted corrective measures submitted by Korean Air Lines Co. on its proposed takeover of As...

JW Pharmaceutical announced on Wednesday that it has relocated its US research center to Boston from San Diego. JW Theriac was first establishe...

South Korea's Mezzion Pharma will seek to get the oral medicine Udenafil to treat side effects from heart surgery, planning to clinical trials in th...

South Korea's SK Geo Centric, the green chemical subsidiary of SK Innovation, will build Asia's largest advanced recycling (pyrolysis) plant in the ...

The British antitrust watchdog raised concerns over the impact on competition of the proposed merger between South Korea’s two largest carrier...

FRANKFURT – Samsung Biologics Co., the world’s largest contract drugmaker, is in talks to develop medicines for a global pharmaceutical ...

With just three days before the world-renowned Frieze Art Fair launches its inaugural event in Seoul, corporate sponsors are duking it out to outs...

A string of South Korean pharmaceutical and biotech companies are waving the white flag when it comes to developing COVID-19 treatments. As the...

South Korean pharmaceutical companies are jumping into the animal medicine and diagnostics market to target the rapidly growing pet care market, whi...

South Korea’s Daewoong Pharmaceutical Co. has obtained approval for the sale of its botulinum toxin product, Nabota, in Saudi Arabia and Ukrai...

A South Korean bio startup is aiming for a Nasdaq listing, deeming that the country’s exchange sets the bar too high for an initial public off...

South Korean biotech and pharmaceutical companies are expanding their footholds in the global space medicine market. Boryung, formerly Boryung Pharm...

South Korean pharmaceutical company Medytox Inc. has filed a complaint with the International Trade Commission (ITC) against Hugel Inc., alleging th...

South Korea’s Hana Financial Group has joined the race to buy English Premier League club Chelsea in a consortium with British property develo...

Samsung Bioepis Co., a biopharmaceutical unit of Samsung Group, plans to double the number of its biosimilar products on sale to 10 by 2025 and acce...

The field of ribonucleic acid (RNA) therapeutics, once considered an unexplored area, is now the most coveted sector in the global biotech industry....

South Korea’s ABL Bio Inc. has signed a $1.06 billion contract to license out its technology for a Parkinson's disease treatment candidate t...

Samsung Biologics Co., a global contract development and manufacturing organization (CDMO), has stepped up its partnerships with global big pharmas ...

South Korea’s SKC Co. is set to invest $33 million in Nexeon Ltd., a British battery materials maker, for the silicon anode materials business...

South Korea’s SKC Co. plans to set up a joint venture with British battery materials maker Nexeon Ltd. for the silicon anode materials market....

London-based private equity firm Permira will maintain its focus on high-quality companies and sector leaders with strong growth potential as valuat...

As concerns rise over a resurgence of the COVID-19 pandemic, the war for talent in South Korea’s pharmaceutical industry is intensifying as th...

South Korea-based Daewoong Pharmaceutical Co. is hoping to achieve 5 trillion won ($4.4 billion) in sales by 2027, meaning that the company aims to ...

CS Wind Corp., the global leader in the wind tower market, has agreed to buy a majority stake in Portugal's largest wind tower manufacturer ASM Indu...

SK Inc., the investment arm of South Korea's SK Group, will launch a 100 billion won ($90 million) fund jointly with Joyvio Group, a unit of Chinese...

South Korea will develop its own messenger ribonucleic acid (mRNA) vaccines by next year with plans to annually manufacture 100 million doses from 2...